Marie Adolphe
Psychiatric/Mental Health · Kissimmee, FLNPI 1881993863
Payments from drug & device makers
Across 356 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$871
- Johnson & Johnson$732
- Otsuka America Pharmaceutical, Inc.$720
- Teva Pharmaceuticals USA, Inc.$524
- plus $2K from 19 others
What the payments were for
- Food & beverage$8,520100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $2,562 |
| Alkermes, Inc. | 41 | $1,288 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $871 |
| Johnson & Johnson | 30 | $732 |
| Otsuka America Pharmaceutical, Inc. | 33 | $720 |
| Teva Pharmaceuticals USA, Inc. | 28 | $524 |
| Neurocrine Biosciences, Inc. | 18 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $258 |
| Vanda Pharmaceuticals Inc. | 9 | $213 |
| Idorsia Pharmaceuticals US Inc | 9 | $154 |
| Lundbeck LLC | 7 | $150 |
| Indivior Inc. | 6 | $126 |
| Livanova USA, Inc. | 1 | $120 |
| Sunovion Pharmaceuticals Inc. | 9 | $106 |
| Ironshore Pharmaceuticals Inc. | 6 | $96 |
| Almatica Pharma LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Tris Pharma Inc | 2 | $34 |
| Viiv Healthcare Company | 1 | $26 |
| Theratechnologies Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $15 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,804
- VRAYLAR$832
- CAPLYTA$498
- ARISTADA$494
- SPRAVATO$125
- ARISTADA INITIO$124
- ABILIFY MAINTENA$122
- VNS Therapy Symmetry Model 8103 Generator$120
- UZEDY$114
How this compares
$8,520 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 12 | $85,072 |
| RexultiBrexpiprazole | 29 | $41,871 |
| VraylarCariprazine Hcl | 24 | $33,231 |
| TrintellixVortioxetine Hydrobromide | 33 | $16,224 |
| Lurasidone Hcl | 34 | $12,526 |
| Aripiprazole | 50 | $4,927 |
| Buspirone Hcl | 223 | $2,278 |
| Duloxetine Hcl | 71 | $1,446 |
| Quetiapine Fumarate | 85 | $709 |
| Trazodone Hcl | 97 | $577 |
| Oxcarbazepine | 24 | $508 |
| Escitalopram Oxalate | 103 | $409 |
| Hydroxyzine Hcl | 29 | $376 |
| Mirtazapine | 54 | $373 |
| Hydroxyzine Pamoate | 49 | $354 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $524 | $85,07212 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $720 | $41,87129 claims |
| AbbVieVraylar | $2,562 | $33,23124 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $258 | $16,22433 claims |
| Almatica Pharma LLCSertraline Hcl | $37 | $18147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Kissimmee
- Roger RiveraKissimmee$1.6M
- Trinese HardyKissimmee$30K
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.